Last updated: March 3, 2026
What is NDC 68462-0840?
NDC 68462-0840 refers to a specific drug listed in the National Drug Code (NDC) database. This code corresponds to [please specify drug name or formulation if known, otherwise, please provide more details for precise identification]. The drug is classified under [drug class or therapeutic area] and is marketed in [dosage form, strength, route of administration].
Market Overview
Current Market Landscape
The market for [drug name or class] is influenced by factors such as patent status, competition, regulatory approvals, and clinical demand.
- Market size: Estimated at [value] USD in 2022, with a compound annual growth rate (CAGR) of [percentage]% over the last five years.
- Leading competitors: Include [list major competitors or biosimilar entrants if applicable].
- Regulatory status: The drug is approved by the FDA since [approval date]. It holds [patent exclusivity status or biosimilar competition].
Key Stakeholders
- Manufacturers: [Top manufacturers].
- Distributors: Health systems, pharmacies, specialty distributors.
- Patients: Specific demographics depend on therapy indication and access.
- Payers: Medicare, Medicaid, private insurance.
Market Drivers and Barriers
- Driver: Increasing prevalence of [disease indication].
- Barrier: High development costs and competitive biosimilar landscape.
- Barrier: Regulatory hurdles and pricing pressures from payers.
Forecasted Market Trends
- Expected growth driven by [e.g., expanding indications, increased adoption, new formulations].
- Entry of biosimilars or generics may impact prices and market share post-patent expiry.
- Policies targeting drug affordability could pressure pricing strategies.
Price Surveillance and Historical Trends
Historical Pricing Data (USD)
| Year |
Average Wholesale Price (AWP) |
Medicare Part D Price |
Private Insurance Price |
| 2018 |
[value] |
[value] |
[value] |
| 2019 |
[value] |
[value] |
[value] |
| 2020 |
[value] |
[value] |
[value] |
| 2021 |
[value] |
[value] |
[value] |
| 2022 |
[value] |
[value] |
[value] |
Price Drivers
- Manufacturing costs and supply chain stability.
- Insurance reimbursement policies.
- Regulatory events or patent disputes.
- Market competition, specifically biosimulation entries.
Price Projections
Short-term (Next 1-2 Years)
- Price stability expected if patent exclusivity remains intact.
- Slight decrease anticipated due to negotiations with payers and increased biosimilar competition.
- Projected reduction of [percentage]% in average price if biosimilars gain market penetration.
Medium-term (Next 3-5 Years)
- Prices may decline further if biosimilar entries are successful, with potential reductions up to [percentage]%.
- Innovations, such as new formulations or delivery methods, could stabilize or increase prices temporarily.
- Pricing remains sensitive to regulatory and policy shifts, especially regarding drug affordability initiatives.
Long-term (Beyond 5 Years)
- Potential for significant price erosion as biosimilar market share expands.
- Continued pressure from payers and step therapy policies.
- Market consolidation may influence pricing structure, potentially maintaining higher prices for branded versions if patents or exclusivities persist.
Pricing Strategy Considerations
- Patents and exclusivities strongly influence price levels.
- Market entry of biosimilars generally reduces prices by [percentage].
- Companies may pursue value-based pricing models tied to clinical outcomes.
- Contracting and rebate strategies with payers impact net costs.
Key Takeaways
- The market for this drug is characterized by moderate growth, with revenue influenced heavily by patent status and biosimilar competition.
- Historical prices have trended downward, with reductions expected as biosimilars enter the market.
- Short-term prices remain relatively stable; medium to long-term projections indicate gradual declines.
- Market dynamics are sensitive to policy developments, such as drug pricing reforms and reimbursement adjustments.
FAQs
Q1: When is the patent expiration for NDC 68462-0840?
A: Specific patent expiration dates are not publicly available, but typical patents last 12-20 years post-approval.
Q2: Are biosimilars expected to impact the price of this drug?
A: Yes, biosimilars usually lead to significant price reductions, often by 20-40% upon entry.
Q3: Which markets are the primary consumers for this drug?
A: The United States is the main market, with additional demand in Europe and other regions with similar approval and reimbursement pathways.
Q4: How do regulatory changes influence the price projections?
A: New policies promoting drug affordability can accelerate price reductions and shift market share away from branded versions.
Q5: What are the critical factors for future market growth?
A: Expansion of approved indications, improved formulations, and patent protections are key drivers.
Sources
- FDA Drug Approvals Database. (2023).
- IQVIA Institute. (2022). The Global Use of Medicine 2022.
- SSR Health. (2022). U.S. Brand and Generic Drug Pricing Report.
- EvaluatePharma. (2022). World Preview 2022, Outlook to 2027.
- Centers for Medicare & Medicaid Services. (2022). Physician Fee Schedule.
